According to official news, Aethir has announced the launch of the internal testing phase for its physically isolated AI agent hosting platform, Aethir Claw Alpha. It is reported that Aethir Claw completely breaks away from the traditional hosting service model of "renting third-party cloud services and reselling them," instead directly utilizing Aethir's own distributed computing power resources valued at over $400 million. Through Aethir Claw, users can not only obtain a fully isolated VPS environment but also opt for a "zero-provider access" mode, ensuring absolute root-level data sovereignty over their AI agents' API keys, conversation logs, and execution actions.
At the same time, the platform comes pre-installed with OpenClaw and will undergo deep customization for business scenarios in subsequent phases. It plans to integrate crypto-native features such as token tracking, on-chain alerts, and whale monitoring, and supports payments via cryptocurrencies like ATH and USDT as well as fiat currency. Furthermore, a "Model as a Service" (MaaS) layer will be introduced in later stages, incorporating open-source large model inference and image/video generation capabilities based on Aethir GPUs, aiming to fully enter the Agentic AI application layer market.
Aethir provides enterprise clients with Kubernetes GPU cluster automation for managing large-scale server clusters. Spanning 94 countries and regions globally, with 435,000 GPU containers across over 200 nodes, it offers extremely low-latency computing power access, reducing overall computing costs by 60% to 80%.
Aethir Announces Launch of Physically Isolated AI Agent Hosting Platform Aethir Claw Alpha Internal Testing Phase
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
2
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
3
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
4
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
5
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
TRIVIA Coin: Originally Designed to Create a Blockchain-Based Trivia Game—Analysis of Current Market Performance and Project Status
-
8
Berkshire Hathaway Holds Record $400B Cash, Net Seller for 3+ Years; "Buffett Indicator" Hits All-Time High Suggesting Stocks Are Expensive
-
9
What Is POLA? Background and Investment Risk Analysis of the Pola On Base Project
-
10
Claiming Social Security benefits at age 62 instead of 67 can reduce monthly payments by 30%, potentially costing average retirees $150,000 over 20 years.
Markets Today
Recommended Reading






